"If you hire a Stock PR firm, it's not always because you like something. It might be because you dislike something."

If on the other hand, you hire a handful of notorious penny stock promoters, as the mysterious third party behind the plethora of pumps for Spencer Pharma has done, then you're doing it to pump the pps of the target, and for no other reason.

And the mysterious third party behind Spencer Pharma have paid for some of the plugs by the following agents, and many more besides:

Too Nice Stocks
WallStreetHustler
TheStockWizards
OTCPicks
TheStockwizards.net
IAB Media
Pennystockpushers
SmallCapPrime.com
PennyStockProphet.com
777Stocks

Not to mention the banner ads apearing all over this and other websites.

Now, ask yourself: why would any anonymous third party be paying all these promoters all this money to pump SPPH's pps

(close to $250,000 in aggregate)

when they "know" that according to SPPH's own PRs, all they have to do is sit on the SPPH stock they own -or buy some more - and they will receive a virtually guaranteed $1.10 per share? ("Virtually guaranteed", that is, by SPPH and their uncritical paid penny stock promoters.)

The answer is, of course, they wouldn't.

There is no doubt that Spencer Pharma is a pump and dump operation, and that Dr. Max Arella has committed scienter after scienter, on behalf of this shady, shadowy Canadian hedge fund that is bankrolling all this Internet promotion (but apparently they don't think it's worthwhile paying SPPH's putative "research partner", INSA, who has not yet received one red cent of the money due to them from SPPH).

Incidentally, SPPH's claimed technology is a crock. No one needs yet another controlled release technology, partuicularly one that hasn't made it out of the test tube into even a rat, let alone a human. To develop any product using this alleged technology would cost millions of dollars and several years - and there's no market for it anyway.

No doubt Arella will release another positive PR full of delberately misleading statements after today's "dinner" - actually a lunch,but dinner sounds so much classier, no?

Don't believe a single word they issue.

Spencer Pharma is a pump and dump scam, pure and simple.

"PercuGuard is a sanitized, disposable, single-use product, which will be launched globally via a marketing campaign to medical boards, government regulators, hospital groups, insurance providers, and other health care product purchasers and participants."


Makes it sound like it's something new, doesn't it?

But actually PercuGuard has been struggling to find a market for ten years now, and Sorrels was working on the design ten years before that apparently:

"June 27, 2000, Tuesday

HEADLINE: INNOVATION;
Dentist's invention protects health care workers from needle injuries

SOURCE: Staff

BYLINE: KELLY PEDERSEN

BODY:
A Houston dentist has developed a device designed to protect medical workers from accidental needle sticks.

Made from a flexible, puncture-resistant covering, the device, called Percuguard, is a flexible plastic sleeve that fits over the finger of the nondominant hand - the hand not holding the syringe - during injections.

Dr. Kevin Sorrels of the University of Texas-Houston Dental Branch began work on the sleeve's design nearly 10 years ago, after sticking himself with a needle while giving an oral injection. The advantage of Percuguard, Sorrels said, is that it is eight to 20 times more puncture-resistant than a latex glove, yet it does not hinder tactile sensitivity like some personal protective products on the market....."

Now at last Dr. Sorrels has found a business model that works.

Just a shame that business model had to be the zero sum old pump 'n dump-erooni.

"Finally we got great news"

Forgive me for asking, but why is confirmation that GVDI is a pump and dump trading shell, passed around freely from the Davis duo to its new owners, marketeers of the singulraly unsuccessful PercuGuard "technology"

(new GVDI CEO Sorrels has been promoting the PercuGuard technology for ten years now, but even so no health care provider I've talked to has ever even heard of it, let alone used it)

good news?

On this occasion, I suspect Mr. Market has for once called this particular Pink Sheet scam correctly.

If anybody had any doubt that GVDI was being developed a shell for stock scams, today's PR should dispel all lingering thoughts that it might be a legitimate business.

Talk about a change in strategic direction - GVDI is now in the "health care" business ( I use the quote marks because both acquisitions look like superficially attractive propositions that in reality are just a cover for this company's real business model - the good ol' fashioned pump and dump.

The highlights in bold are my way of emphasising particular points of interest:

"Golden Valley Development, Inc. Announces Acquisition of Two Companies
Date : 11/29/2010 @ 5:00AM
Source : Business Wire
Stock : Golden Valley Development, Inc. (GVDI)
Quote : 0.0139 0.0 (0.00%) @ 2:05AM


Golden Valley Development, Inc. Announces Acquisition of Two Companies

Today : Monday 29 November 2010
Golden Valley Development, Inc. (OTC:GVDI) is pleased to announce that it has recently completed the acquisition of two new companies, each having a licensing agreement to manufacture and market a new patented technology.

First, Golden Valley has acquired Digit-Pro, a Florida company which has a licensing agreement to manufacture, market and distribute the patented “PercuGuard”TM, an FDA-approved protective device marketed to the health care industry, which protects the health care worker from accidental exposure to HIV, hepatitis and other blood-borne pathogens which can occur during the application of hypodermic needle injections into patients. PercuGuard is a sanitized, disposable, single-use product, which will be launched globally via a marketing campaign to medical boards, government regulators, hospital groups, insurance providers, and other health care product purchasers and participants.

Second, Golden Valley has acquired a Delaware corporation doing business as Cut Stop, which has a licensing agreement to manufacture, market and distribute the patented “Cut Stop”TM finger guard technology.

“Cut Stop” is a version of the PercuGuard technology, which has been modified for the home consumer market. Cut Stop guards the fingers from accidental cutting by knives and other sharp instruments in the home while cooking, cleaning, etc.

In connection with these two acquisitions, Management for Golden Valley has resigned and appointed new management personnel in their place.

Golden Valley’s new President, CEO, Secretary, Treasurer and Chairman of the Board of Directors is Kevin Sorrels, D.D.S., an inventor with over twenty years experience in the health care industry, having served over 4,000 patients through the course of his 15 year long preventive and general dentistry practice.

Golden Valley’s new Vice-President, COO and director, is Carter Ransom, a thirty-year veteran of international sales and business development, specializing in product and technology launches. Prior to Golden Valley, Mr. Ransom was most recently Vice-President of Global Strategic Alliances at Diskeeper Corporation, implementing software technology licensing programs with computer manufacturers throughout Asia and the United States. Before his work with Diskeeper, Mr. Ransom was involved with the successful start-ups of several emerging technology companies such as Digital Island, and spent 10 years in sales and operations management for Sony Business and Professional Group, launching numerous technology-driven Sony products and services.

“We’re very excited to take over the business of Golden Valley and add our new patented products,” said newly-appointed President and CEO, Kevin Sorrels. “We look forward to manufacturing and selling our Cut Stop and PercuGuard products to their respective markets and in so doing generating self-sustaining revenues for the company.”

Golden Valley’s new VP and COO, Carter Ransom, agreed, adding: “We consider Cut Stop and PercuGuard just the first two of what we hope will be a series of successfully-sold new patent-dependent products.”

The company’s new website is www.goldenvalleydev.com and its physical headquarters are located in Clearwater, Florida.

About Golden Valley Development, Inc.

Golden Valley Development, Inc. is a publicly-traded Clearwater, Florida-based manufacturer and marketer of patented products in the health care and home consumer markets, currently launching its first two products, “Cut Stop”TM and “PercuGuard”TM.

Forward-Looking Statements

Portions of this press release contain forward-looking statements and involve risks and uncertainties that could materially affect expected results of operations, liquidity, cash flows and business prospects."

"Can anyone share w/me what the deadline is to get in on this $1.10 per share deal? Is this for real?"

I suggest you do at least some rudimentary research on your own behalf, starting with this message board, including the iBox, and the posts both for and against the proposition that this stock is a scam, (and a very transparent one at that).

A tip o' the hat, too, to Brad S for bringing the following website to my attention. I recommend it thoroughly (and not only because it links to my own posts several times):

http://otcandpinksheetdirtylittlesecrets.blogspot.com/2010/11/train-wrecks-everywhere-christmas-has.html

Almost 3,000 companies received money from the pork-barrel QDTP program that BIPH insider tetrahedron aka Max Bialystock aka Marc Bielski seems to regard as a validation of MCC's (by now ancient) technology:

"We believe the award of these grants is an acknowledgment of the importance of MCC’s technology"

I seem to remember Lanzafame saying something similar when Biophan stole $1 million of the taxpayers' money courtesy of Congresswoman Louise Slaughter and then put it directly into the pockets of Weiner, Lanzafame, the Anstadts and their other crooked associates:

http://www.biophan.com/index2.php?option=com_content&do_pdf=1&id=443


In fact the major qualifications to receive a QDTP grant seem to have been the ability to write a plausible story and a possession of a BoD with a least one viable pulse rate*:


"Biotechs get $1bn in US grants

Nearly 3,000 small biotech companies across the US have been awarded grants and tax credits totalling $1bn. The government money was earmarked under the healthcare reform legislation for new therapeutic discovery projects.

The grants and credits, which are jointly known as the Therapeutic Discovery Project, were announced by secretary of the treasury Tim Geithner, secretary of health and human services Kathleen Sebelius, and National Institutes of Health (NIH) director Dr Francis Collins.

"These grants will help make sure our companies, entrepreneurs and workers can continue to invest and innovate, which will strengthen our economy now and far into the future," Geithner said.

Sebelius said the funding would allow companies "to hire more staff, improve facilities and move forward with research projects that might otherwise have been put on hold." The funding is intended in part to keep the biotech companies from moving their research activities overseas, she added.

The government reviewed 4,606 applications from biotech companies and awarded grants and credits to 2,923 companies specialising in biotechnology and medical research in 47 states and the District of Columbia.

The grant funding is aimed at supporting research that shows significant potential to produce new therapies, address unmet medical needs, reduce the long-term growth of healthcare costs, or advance the goal of curing cancer within the next 30 years.

The tax credits cover up to half the cost of qualifying research and are only available to companies that employ fewer than 250 people. The credits can be applied to investments made in 2009 and 2010."

The reality is that over the years the crooks behind Biophan and now MCC(that would be Technology Innovations through their various scams such as Natural Nano/Combotex)have had tens of millions of dollars at their disposal all raised with the seeming objective of seeking to

"to get our device into clinical trials and into the marketplace faster"

but every penny of that money has ended up in the pockets of the Rochester mafia, while the MCC 3000 (as it is called in its latest reincarnation) has advanced not one jot.

As the old saying has it:

"Fool me once, shame on you. Fool me twice (or eighteen times, in the case of BIPH/MCC), shame on me"

*There can be little doubt that among the worthy recipients of such grants were also a few criminal enterprises. Another one of these is Pro-Pharma, which also received a QDTP, but is also a criminal enterprise, just like BIPH, which happens to have the same CEO as MyoCardioCare, John Lanzafame:

http://messages.finance.yahoo.com/Stocks_%28A_to_Z%29/Stocks_P/threadview?m=tm&bn=90221&tid=9232&mid=9232&tof=-1&rt=1&frt=2&off=1

"This thing has scam written all over it."

It surely does. See the iBox and my other posts for more details, including an analysis of why Spencer Pharma's underlying "technology" is not novel, useful or even close to being able to be commercialised.

"And why would someone pay $30,000 to 777stocks.com...?"

Good question.

And the same "someone" has paid IAB Media, and numerous other penny stock pimps.

(A number of posters with a disclosure notice left this MB soon after I arrived, including the then Moderator, but they were soon replaced by other equally enthusiastic posters with no disclosure).

We can be sure that the mysterious third party isn't directly funded by Spencer Pharma, for SPPH has less than $1,000 in the bank (and there are no zeroes missing from that number, in case you were wondering).

A better bet is that they are the shadowy private Canadian hedge fund bankrolling SPPH's expenses, according to the one PR where Dr. Arella has disclosed (at least, but only part) part of the truth:

"The company is currently being funded by a small independent fund located in Canada."

http://ih.advfn.com/p.php?pid=nmona&article=45157528

Shame they couldn't afford to pay SPPH's research "partner", INSA:

"However, it should be noted that the partnership with INSA requires a payment of approximately $150,000 every quarter and the company has not yet provided the said payment and the partnership is on hold until such time as the payment can be made."

which would appear to be a better use of funds that trying to pimp the Spencer Pharma pps when a buyout - a buyout that these gentlemen hiring the penny stock promoters would have you believe is virtualy guaranteed - is apparently on the way.

I can absolutely guarantee that Spencer Pharma is a scam.

What's really interesting is who is behind the scam, and whether there are there US companies involved in this criminal conspiracy as well as Canadian companies. And I intend to find out.

Watch this space, as they say.

"This is from a poster that spoke with Art after the last PR."

I suspect this should actually read:

"This is from a poster who claims that he spoke with Art after the last PR."

For some reason the old adage

"Fool me once, shame on you; fool me twice, shame on me."

springs immediately to mind whenever I read the GVDI MB nowadays.

PS Call me a curmudgeonly old glass half-empty pessimist, but I fail to see zero volume for several hours for GVDI today as a particularly positive sign.

"If there is a merger in the works"

Just who is it you think GVDI might be merging with?

(Now that we know the real estate merger was a complete hoax, which the real GVDI's "management" knew about for months, but nevertheless were for some strange reason disinclined to mention that it was a hoax to their shareholders, even though they would have had to have been living on Mars not to know what the common belief among GVDI's stockholders was.)

A giant Brussels sprout perhaps? An enormous Zucchini? Perhaps a elephantine egg plant? A colossal cabbage?

Given GVDI's declared line of business, those are all options that would make more sense than the other wild speculations on this message board.

Mark my words, this will all turn out very badly, except for a small group of day-traders with immaculate timing and more than their fair share of luck.

"rhump, the company is called Al Dorra"

Actually up until yesterday's PR, Spencer Pharma had always referred to "Al-Dora" which is quite a different company to Al-Dorra. Yesterday's and today's PRs refer to Al-Dorra, probably in a deliberate attempt to obfusticate the issue.

The real Al-Dorra (http://www.al-dorra.com/) is as you say a petroleum services company with a totally different set of principals and a totally different phone number to the "Al-Dora" originally mentioned by SPPH, which not only did not exist on the web until mentioned by Spencer Pharmaceuticals, but its phone number is actually a United Arab Emirates cell phone number, not even a Kuwaiti number.

The real Al-Dorra profess to know nothing about Spencer Pharma or any deal, so it must be a different company to which Arella refers.

And, as I think we all know by now, a completely made-up company at that, much like SPPH itself.

"I don't know if Canada stages raids like the F.B.I. is doing in tandem with the SEC on the insider trading scandal, but they should."

I wouldn't hold out much hope that SEC will get round to dealing with Spencer Pharmaceuticals any time soon.

The sad fact is that when it comes to Pink Sheet fraud, the SEC doesn't have time to get involved with every single scam -at any one time there are dozens, if not hundreds in operation.

Which is why it issues the generic advice you can find here:

http://www.sec.gov/investor/pubs/pump.htm

I have known very obvious scams continue for literally years. For example, Green Energy Resources put out fantastic ( in the sense of being pure fantasy) PRs for many years, with the illiteracy of the PRs being matched by the increasingly ludicrous claims being made. Probably hundreds of complaints were made to SEC during that time. But it took a typically far-fetched PR claiming that Green Energy Resources were going to clean up the BP Gulf of Mexico Oil spill to spur SEC into action. You can see some of the history here:

http://investorshub.advfn.com/boards/board.aspx?board_id=3721

Several years ago, SEC announced a new policy of acting together with FDA to counteract the wilder claims being made for biopharmaceuticals, which along with alt.energy is one of the most fertile stamping grounds for fraudsters like Dr. Arella and his bosses:

http://www.ropesgray.com/fdatocooperate/?PublicationTypes=0c16874b-f94e-4696-b607-de259b87a13f

Sadly nothing came of this, because FDA would be able to tell SEC in a heartbeat that Spencer Pharmaceuticals' claims for its modified release technology are wild and unsubstantiable.

Here is today's instalment in the increasingly long-running saga of the SPPH scam:

http://www.redinews.com/cgi-bin/showart?queryid=QG31728&article=L327inw0121

As I have previously remarked, the size of the authorised issue, the outstanding total of shares and the actual float is pretty well unknowable for any Pink Sheet company, let alone one like SPPH which has never filed with SEC.

They could say absolutely anything they wanted to, and we would have no way of knowing whether it was true or not.

Except that to date, any verifiable statement they have made, such as the approval forecasts for Met4, have turned out to be false in terms of both date and geography, and everything else about this company tells us that Dr. Max Arella is a big fat liar, doing his big fat lying on behalf of some shadowy mysterious Canadian Hedge Fund.

The only real questions about this scam is whether or not it's an independent operation, or like so many similar operations, it is run by organised crime. If the latter, you might expect the Canadian mafia family run by the Rizzuttos to be in cahoots with their allies South of the Border, particularly the Bonnano and/or Gambino families, who tend to specialize in this kind of thing.

"I highly doubt that investorshub has disclosed his identity to thus allow NNAN to sue him."

The Natural Nano insider posting the "incoherent gibberish" you mention is laboring under the delusion that I am one of the many past employees of either NNAN or Combotex who is now suing NNAN (Combotex is one of the other scams operating out of Schoen Place which has now been folded into NNAN).

I am certainly not a past employee of NNAN, although several past employees have contacted me in confidence (voldemort2001@hotmail.com) to confirm my impression that these are highly suspect operations and to give me specifics.


The fact remains that Technology Innovations LLC exists solely to divert private retail shareholders' money to the capacious and rapacious pockets of Messrs Weiner, Wernett et al.

A cursory study of the history of Combotex (Google Ted Tackaberry/Tackleberry and Combotex), Biophan and Natural Nano itself will soon confirm this to be the case to any rational individual.

As for suing me, Mr. Wernett or any of the other crooks associated with the skein of fraudulent operations run by TI/NNAN is welcome to serve me at the above email address. I promise to respond, (I look forward to the Discovery process with interest and enthusiasm) and indeed to launch my own countersuit for malicious prosecution.

However given the likely involvement of organised crime in this rather sordid affair, you can be sure I will act strictly through my attorneys, and will not divulge my home address for obvious reasons.

"Is there any chance the stock is legit and something worth investing in at the current price?"

None at all, no.

If you strip away the almost daily bogus PRs, the accomodation address in the US, the Pink Sheet listing (complete with warning about lack of information), the fact that they have almost literally no cash, and a self-determined asset (the patent) of $100,000, a third party who pays for numerous penny stock promoters to hype this thing all over the Internet, Arella's previous history with scam company HZHI, and the secretive nature of SPPH's mysterious Canadian backers (think Rizzuto again), and look at the underlying "technology" and its promise, what do you see?

They apparently have some sustained or modified release technology, that has never been tested in a lab rat or mouse, let alone a human being. That means that even in a generic formulation (which would not allow any kind of premium price) they are years away from any market, because they need to do animal studies, CMC definition, pharmacodynamic and pharmacokinetic studies on each and every formulation they intend to apply for, and finally they need to conduct comparative clinical studies, versus either placebo or just possibly for the generic route versus an active comparator.

Such a development program would take at least five years and cost millions of dollars for every drug candidate they think they have. And there would be no guarantee of success even then - many such formulations fail at either the pre-clinical or clinical stage.

The form they seem to be saying is most advanced is their MR version of metformin. Metformin is a an ancient drug, with many generics, including modified and sustained release versions, already available on the market in every country, including the US, the EU and Canada. There's simply no need and no demand for yet another metformin formulation.

All this assumes that Spencer even have some technology. On the grounds of the lies in their previous PRs concerning the approvability of this technology, then I doubt they have anything other than a vague idea, which they have patented. I suspect that any patent they may have would fall immediately when challenged, because there is so much prior art in delivery mechanisms.

No reasonable person with any knowledge of either the biopharmaceutical business or the nature of penny stock scams could doubt that Spencer Pharmaceuticals is an utterly fraudulent pump and dump operation, and not a very plausible one at that.

"Well they just posted news that they recieved $500,000 non-refunable deposit"

Actually they posted news that they have a "commitment" for the half a million bucks, as the headline of today's PR makes clear, although of course, they want you to misread it and assume they actually have the money, just as you did:


"Spencer Pharmaceutical Receives a $500,000 Non-Refundable Deposit Commitment From Al-Dorra"

However, as we have come to expect, the title of the PR is highly misleading, because as the main body of the PR makes clear this $500,000 has not yet hit Spencer Pharmaceutical's bank account:

"This commitment, the form of which will be determined, will be non-refundable. According to the letter by Al-Dorra, they will forward this commitment on or before November 30, 2010."

And, of course, it never will.

(Incidentally, the PR refers to "Al-Dorra", whereas all their previous PRs have referred to "Al-Dora". This is an error,albeit probably an intentional error, as Kuwait-based Al-Dorra is a perfectly respectable company (http://www.al-dorra.com/) which has nothing to do with the fictional entity Al-Dora (based in UAE according to the mobile number of one of its principals) which was established with the sole intent of robbing investors via the SPPH pump and dump scam. Doubtless Dr. Arella and his puppet masters would like you to confuse the two, although they may have gone a step too far this time.)

So no money has changed hands, in spite of the grossly misleading leading headline on the PR.

Frankly, given the outrageous nature of Spencer Pharmaceuticals' previous lies about the approval and marketing of Met4 and its other alleged products, the fact that in fact they do not have US offices but simply an accomodation address, the tens of thousands of dollars that are being spent by a mysterious third-party on propagating SPPH's fictional PRs across the Internet via various sleazy penny stock promoters such as IAB, then even if they said they'd received the money in the body of the text, I simply wouldn't believe it.

And neither should you.

NNAN's real owners, the toxic finance hedge funds Platinum and Longview, ultimately controlled by the shadowy company behind all those different 15 Schoen Place scams, Technology Innovations, LLC, must be getting very desperate.

As they obviously can't refute the fact that they are intimately associated with a number of different scams such as Combotex (look up Combotex and Ted Tackaberry/Tackleberry), Biophan and all the others, instead they hire someone to spread the most vile and false rumors you can possibly imagine on the message boards, none of which are true.

I guess it is possible that those vile accusations may well be aimed at one of the many ex-employees suing NNAN - those who chose to work for the crooks at NNAN and BIPH in the past must have known they were actively involved with a scam, so they can scarcely be surprised if Weiner, Wernett, Lanzafame and their other criminal associates try to deflect attention from the undoubted pump and dump con-trick that is Natural Nano while trying to wreak vengeance on their former accomplices.

"Even to the point of open libel of the company and it's [sic] officers."

When I call Dr. Max Arella and his associates lying crooks who are knowingly committing scienter after scienter, that's not libel, that's simply the truth.

They are welcome to sue me if they wish, although I will look forward to both the Discovery process, and to my malicious prosecution countersuit.

And as for the nonsense about "Al-Dora" ( the hitherto non-existent third party allegedly buying SPPH) wanting to talk the price down, that's self-evident nonsense. If the (phantom and fictional)deal had not been announced, and "Al-Dora" had insisted that it not be announced, which if they actually existed they would have been able to do, then no one would have known about the (bogus) offer, and they could have bought as many shares in the open market as they wanted.

The string of false PR after false PR can only mean one thing - SPPH is a pump and dump operation run by its "management" on behalf of a shady Canadian hedge fund.

"Doing a "google" search on a stock like SPPH it can be hard to get critical information"

Agreed, although here's one of the better reports I have seen, from www.hotstocked.com, dating from October 29, and therefore before the most recent scienters the company have committed:

"Spencer Pharmaceutical Inc. (PINK:SPPH) Makes Record Volume on Trading Alerts

By Violeta Slavtchevska
Date: Oct 29, 2010
Two weeks after the last disclosed promotion for Spencer Pharmaceutical Inc. (PINK:SPPH, SPPH message board) stock, its share price jumped up again yesterday on the highest trading volume in its history. The winning PR strategy again involved two press releases and numerous trading alerts.
Yesterday, over 767,000 shares of the rarely traded SPPH stock turned over on the market, but the share price increase was modest for a pink sheets stock.

SPPH added only 4.72% to its market value and closed the session at $0.335. Along with the unprecedented trading volume, the second success of the promoters was the highest price given during the day. It was $0.38, which is a break up of the usual trading range of between $0.245 and $0.362.

After $11,000 in cash were paid in the middle of the month for the advertisement of SPPH shares, yesterday another stock promoter was compensated to increase the public awareness. A third party [my emphasis] paid $5,000 for a one-day awareness campaign, which included the sending of a number of trading alerts. The unconfirmed and extremely doubtful information [my emphasis]disseminated has been supplied by the company itself.

Spencer have never filed any material information with the SEC. Among other things, yesterday the company said that they have hired an independent laboratory to do animal test of their "new met4 formulation".

The only problem is that according to Spencer's last available financial reports they have no cash and their only asset are certain patents valued at the company's own discretion at around $100,000. No research or development activities can be recognized, the cash at hand has been spent only for general and administrative purposes and the existence of the proclaimed "new met4 formulation" has not even been mentioned."

http://www.hotstocked.com/article/3193/spencer-pharmaceutical-inc-pink-spph-makes.html

So the Biophan pump is on again, eh?

"MyoCardioCare, Inc. Appoints Renowned Surgeon Dr. Gus Vlahakes to Scientific Advisory Board"

I noticed renewed activity from another of TI's 15 Schoen Place-based scams, Natural Nano, this week too, which has been aggressively (but unsuccessfully) promoted by some of the usual momo players over on the message boards:

http://investorshub.advfn.com/boards/board.aspx?board_id=5710

(Incidentally NNAN has combined with yet another Schoen Place-based scam, Combotex, recently - Combotex is the employer of fraudster and despoiler of Pittsford senior citizens' IRAs, Ted Tackaberry/Tackleberry).

Obviously the Rochester Mafia thinks it's safe to venture outdoors again:

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=50436189

As tetrahedron, aka Max Bialystock aka Marc Bielski, Director of new Lanzafame shell, MyoCardioCare has now been identified by himself as an official MCC and Biophan insider, presumably he's going to have to use a different screen name when committing scienters on behalf of Weiner, Lanzafame and his other TI paymasters.

I wonder if we will all be able to spot it?

"we have an interesting week ahead!!!"

With yesterday's 10% drop in pps, and the more astute momo players cottoning on to the plain facts that Natural Nano is in reality:

- a sorry shell formed out of a bogus "nanotechnology" company, combined with a check list manufacturer associated with a known fraudster (Ted Tackleberry/Tackaberry)-

- entirely controlled by a shady toxic finance hedge fund,Platinum, also associated with private vehicle, Technology Innovations LLC, designed specifically to drain money from private retail investors and give it to TI and its crooked principals such as Michael Weiner,

- the subject of numerous lawsuits, not least from a bunch of previous employees including the past CEO, all of whom I suspect have an interesting story to tell

- making huge losses of over $1 million per year

- technically insolvent, with current assets dwarfed by liabilities

it could indeed be an "interesting week".

Perhaps the SEC will take its much-anticipated long hard look at Natural Nano?

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=50436189

"it is pretty clear what his/her thoughts are on this stock"

True enough. I think it's an out-and-out scam. I have many years' experience in the biopharmaceutical industry in the US and internationally, and I can guarantee you that Spencer Pharmaceuticals so-called drug delivery technology is both years and millions of dollars away from the market, and that even if it were to make it to market, there is nothing noteworthy about this technology.

I also know that no reputable company PRs a "dinner(lunch)" with an alleged partner that has only just spru7ng into existrence, let alone tries to flog tickets for $1,000 a head to the sforesaid "dinner (lunch)" to curious punters.

"you need to do your own DD and decide for yourself as with any stock"


I strongly agree with this. Please ensure that this DD includes talking to someone who knows both the science and the regulatory sides of the biopharmaceutical industry.

Be sure to show them Dr. Arella's PRs, all of them. When they've finished laughing, they'll tell you what you need to know.

Canadian penny stock promoter Agora.com (recently in the news for various nefarious activities:

http://www.osc.gov.on.ca/en/Proceedings_set_20101110_agoracom.htm)


and US penny stock promoter Agora Financial.


Are they by any chance related to each other, or is just coincidence that they share the same name and same shady type of clients?

TIA.

"The Official dinner will be held in honor of Al-Dora and their representatives and will be $1,000 per person, whereby the proceeds will be given to a charity of Al-Dora's choice. Government Officials, members of the bio-technology community, shareholders, partners, and members of the media are welcome to RSVP at info@spencerpharmaceutical.com, limited space available. It should be noted that the individual payment shall be received no later than November 26, 2010, to be admitted to the dinner; no access will be granted the day of the event due to security reasons."

I was going to say you couldn't make this stuff up if you tried, but Max Arella obviously can.

Apart from the SEC

(whose budget sadly will not stretch to a trip North of the Border - strange a US quoted coapny would host a "dinner(lunch)" (sic)in Canada, but there you go)

or the Royal Canadian Mounted Police, I somewhat doubt that any Government officials will be forking out $1,000 to have "dinner(lunch)" with crook Dr. Max Arella, and a couple of Arabic gentlemen stright from central casting.

And as for Al-Dora buying shares in the open market, they ain't. Firstly it would take them a hundred days even at a high volume day for SPPH (and that's assuming the float they give to Pink Sheets is accurate, which I doubt, given that everything else that SPPH publishes is a web of lies fromn start to finish) and secondly Al-Dora is a made-up company, designed specifically to suck money from your pockets and put it in the pockets of Dr. Arella and his shady Canadian hedge fund backers.

Caveat emptor indeed!

"Sales Revenue Increases 318%"

Sounds great doesn't it?

Until you realise that sales were literally negligible in 2009, and that the 2010 figures include Combotex sales from April 2010.

(Combotex, by the way, is associated with known fraudster Ted Tackaberry/Tackleberry. Sounds like an ideal partner for Wernett's toxic hedge fund associates/employers at Platinum, the shady private company that used Natural Nano as an arbitrage vehicle until they got too greedy and killed the goose that was laying the golden eggs.)

The important figures are profits:

Down from a loss of $156 k in the first nine months of 2009 to a huge loss of $736k in the same period in 2010.

and cash flow:

Cash was down from $90k in 2009 to just over $1,000 (no k - just one thousand dollars) this year.

In fact NNAN is now technically insolvent, and I suspect in reality also. In law the Directors of this company should be acknowledging that fact and dissolving the company.

Add to those sad statistics the incredible further dilution, for example this little gem:

"During the first nine months of 2010, the Company issued an aggregate of 18,922,832 shares of common stock to various individuals or entities in connection with professional consulting, lab and research services, facility rent, and website assistance provided to the Company in an aggregate amount of $60,259."

which meant that the weighted average shares outstanding went from 72 million in 2009 to 133 million in 2010, almost 100%. The current figure, of course, will be way above 132 million as that is an average across the year.

And there's more, material weaknesses in previous accounts:

"Based on this evaluation, and in light of the material weaknesses in our internal control over financial reporting that are discussed in our Annual Report on Form 10-K for the fiscal year ended December 31, 2009 our Chief Executive Officer has concluded that our disclosure controls and procedures were not effective. The material weaknesses consist of an insufficient complement of qualified accounting personnel and controls associated with segregation of duties and ineffective controls associated with identifying and accounting for complex and non-routine transactions in accordance with U.S. generally accepted accounting principles."
Clearly NNAN should carry a "going concern" warning, and could disappear any day.

The only reason for the shares ever to be up rather than down is because of the fact that everybody reads NNANs puff PRs and listens to the momo players, and nobody read the 10Q or other SEC filings.

Time they started doing proper Due Diligence:

http://ih.advfn.com/p.php?pid=nmona&article=45246221

"News, Is this good enought?? for it to go back up"

No.

First off the results from SPPH's scientists (SPPH doesn't have any scientists, but I'll let that ride for now)concerned purely in vitro results - literally in a test tube, and have been nowhere near a living being, not even a mouse, let alone a human.

Secondly there are many other sustained and modified release versions of ibuprofen available already. No need to wait the several years and millions of dollars it would take to get SPPH's product on to the market.

Thirdly, assuming that SPPH's technology is indeed patentable (doubtful - every technology under the sun has laready been thought of, and there's certainly nothing novel about MR ibuprofen!), then by publishing today's PR prior to applying for a patent, then Arella has already invalidated his application due to "prior art".


Other than that, it's a very encouraging PR.

As I've said before, no one should buy and hold any biopharmaceutical stock unless they understand the scientific and regulatory rudiments of this business.

And if they did have that basic grasp, they would never buy SPPH which is very clearly 100% scam, and 0% science.

"but now you know why people are bying big."

So your case is that yesterday's rise is down to insider trading (or alternatively a scienter committed by folk looking to boost GVDI's pps)?

I'm not sure that should do anything to reassure people about the probity of the Davis duo or others involved in this company.

The more I look at GVDI, the more I become convinced it's going to end in tears. I hope it won't just be the investors who end up crying, but rather the crooks behind the unfounded pump on merger rumors - rumors that nobody at GVDI could be bothered to suppress or refute for months, even though they knew all about it.

"971 is country code and following 50 is for mobile/wireless."

Besides which the country code for Kuwait, which is where previously unheard of Al-Dora, not to be confused with entirely respectable and legitimate Al-Dorra

(who have never heard of Al-Dora or either of the "His Excellencies" mentioned on Arella's wholly fabricated PR:

"Al-Dora Holdings is a Kuwaiti private investment company owned and managed by some of the Gulf's richest families. The Al-Dora Holdings is represented by its chairman, His Excellency Dr. Bandar Al-Dhafiri and its CEO His Excellency Hussein Al-Awaid.")

is allegedly based, is +965.

The country code given for the newly minted Al-Dora and its mysterious principals is an United Arab Emirates code, +971, which is quite a different country to Kuwait.

I wonder why "Al-Dora", which Arella claims is based in Kuwait, has a UAE phone number?

Perhaps for the same reason that Canadian outfit SPPH has an accomodation address in the US.

And BTW, Hajj does not extend into December, as implied by Arella's lie of today:

"The companies' representatives are schedule to hold a meeting in Canada to negotiate a definitive agreement on or before December 22, 2010, this is respecting the Muslim holidays which are currently in effect."

In fact Hajj finishes on the 19 or 20 November, and Arella's timelines imply that negotiations were ongoing throughout Hajj, which would be odd under the circumstances he hints at.

Contrary to what some have claimed, the alleged prospective purchaser of Spencer Pharmaceuticals, Al-Dora, has nothing to do with Al-Dorra, a perfectly respectable Petroleum services group operating out of Kuwait:

http://www.al-dorra.com/

I'm sure Dr. Arella is hoping other people will also be confused, and I suspect he designed today's latest work of fiction to encourage that confusion:

"(In the translation from Arabic to English, Al-Dora is sometimes spelled Dorra and/or Dura). The Al-Dora Group has investments in the financial sector, oil and gas, pharmaceutical, and real estate."


Nevertheless the fact remains that until today the mere existence of a group called Al-Dora was unknown on the World Wide Web.

Which is kind of convenient, at least if you're a crook and fraudster like Dr. Max Arella.

"SPPH LOAD THIS DIP TOO"

It's probably worth mentioning at this stage, that until this morning nobody had heard of Al-Dora holdings. They are literally without a single mention on Google or any other search engine until they miraculously pop into existence on SPPH's latest entirely fictional PR.


The phone number will doubtless just lead to more of Dr. Arella's co-conspirators.

Gulf countries have a rather harsh attitude towards those who try to defraud Arabian investors -it's a shame SEC are not always so diligent.

"Sales Revenue Increases 318%"

Sounds great doesn't it?

Until you realise that sales were literaly negligible in 2009, and that the 2010 figures include Combotex sales from April 2010.

The important figures are profits:

Down from a loss of $156 k in the first nine months of 2009 to a huge loss of $736k in the same period in 2010.

and cash flow:

Cash was down from $90k in 2009 to just over $1,000 (no k - just one thousand dollars) this year.

In fact NNAN is now technically insolvent, and I suspect in reality also. In law the Directors of this company should be acknowledging that fact and dissolving the company.

Add to those sad statistics the incredible further dilution, for example this little gem:

"During the first nine months of 2010, the Company issued an aggregate of 18,922,832 shares of common stock to various individuals or entities in connection with professional consulting, lab and research services, facility rent, and website assistance provided to the Company in an aggregate amount of $60,259."

which meant that the weighted average shares outstanding went from 72 million in 2009 to 133 million in 2010, almost 100%. The current figure, of course, will be way above 132 million as that is an average across the year.

And there's more, material weaknesses in previous accoubts:

"Based on this evaluation, and in light of the material weaknesses in our internal control over financial reporting that are discussed in our Annual Report on Form 10-K for the fiscal year ended December 31, 2009 our Chief Executive Officer has concluded that our disclosure controls and procedures were not effective. The material weaknesses consist of an insufficient complement of qualified accounting personnel and controls associated with segregation of duties and ineffective controls associated with identifying and accounting for complex and non-routine transactions in accordance with U.S. generally accepted accounting principles."

Clearly NNAN should carry a "going concern" warning, and could disappear any day.

The only reason for the shares to be up rather than down this morning is because of the fact that everybody read the puff PR, and nobody read the 10Q:

http://ih.advfn.com/p.php?pid=nmona&article=45246221

"Well Dr. B would have said something at the share holder meeting because bad news would have been known."

And there are fairies at the bottom of my garden, as the more sceptical English person likes to say.

It would be a shocker if the positive results of all of HDVY's technology in the hands of Dr. Fritsche turned out not to be validated by Abbott and Quest's own studies.

After all, what possible reason could Dr. Fritsche have for consciously or unconsciously arriving at false results in his laboratories, which is where all of HDVY's studies on this technology were conducted?

Other than being Chairman of HDVY's Scientific Advisory Board for many years, a major shareholder, quoted spokesperson on all their PRs and hoping for a full time job when he stepped down from academia, obviously.

But other than those four factors, no reason at all. And the fact that he was successful in that last endeavor is another one of those spooky coincidences to which the committed HDVY long should certainly pay no nevermind.

"email was sent by: From: Simon Says Stocks"

That would be Simon Says Stocks, which, being an IAB company, has the following disclaimer on its website:

"16) SPPH:
IAB Media Inc. has received 24,000,000 restricted shares from Spencer Pharmaceutical Inc. on 2009-12-16
The agreement was amended on 2010-10-07 to reduce the number of restricted shares as compensation to 4,000,000 and the 20,000,000 remaining shares were returned to the SPPH treasury."

http://www.simonsaystocks.net/#disclaimer

Thought so.

I don't know who sent you the email, but they should be more critical in their reporting.

For example when they say:

"The reason is Spencer received an all cash buyout offer from an undisclosed party at $0.97 per share."

what they should be saying is:

"The reason is Spencer claimed to have received an all cash buyout offer from an undisclosed party at $0.97 per share."

That way they wouldn't merely be parroting SPPH's original lie, but at least distancing themselves from one of Dr. Arella's many scienters.

I dare say the email was sent by one of the many penny stock promoters that SPPH seems to be able to afford to employ, even though they have less than $200 in cash, and are in default to their so-called research partner, INSA.

Shows an odd sense of priorities, if you ask me.

Unless, of course, Spencer Pharmaceuticals is setting up itself up as the front for a pump and dump operation, in which case spending money (or more accurately your hidden hedge partner's money) on promoting your stock rather than R&D makes perfect sense.

Caveat emptor!

"why is it going down?"

Because Spencer Pharmaceuticals is a worthless pump and dump shell, and because one would have to have a single digit IQ to afford any credibility to the works of complete fiction that Dr. Max Arella cooks up in his home office in Canada, and then releases as PRs to a US audience.

If you're still holding, you may find this website of assistance:

https://denebleo.sec.gov/tcr/add.action?c=12

Hope it helps.

"We understand that there is a lot of scientism"

Scientism? Scientism??

I presume the good Dr. Arella means scepticism, but for obvious reasons the word that stuck in his mind was "scienter" - because this whole PR is a web of illegal scienters. (Obviously another PR not reviewed by anybody literate or intelligent, let alone the lawyers).

"We can only assure our shareholders that we are working diligently and in good faith."

Don't believe you, Dr. Max. You have admitted you lied about the alleged approvals for Met4 in the US, Canada and the EU by June 2011, and every other PR you have published is based on unverifiable sources or is actually an outright lie.

You can't even pay your erstwhile partner, French research institute, INSA, the minimal amount required under terms of your much-vaunted partnership - which as a result appears to be still-born. Given that SPPH's cash assets are less than $200 - I kid you not, less than $200 - that's not entirely suprising.

What is surprising is that even though they have no cash, there are banner ads for SPPH all over iHub. Wonder which small private Canadian hedge fund is paying for those? I know why, obviously - you can't conduct a good pump and dump operation unless you can whip up some froth and excitement, I just wonder who is behind it.

"The offering party is not an American company and the cultural differences and language sometimes require more attention," further added Dr. Arella."

You betcha. These companies based in Never Never Land are really difficult to do business with. That will doubtless be one of the excuses trotted out when this utterly bogus buy-out offer is finally abandoned.

"IFUS must sell shares to stay afloat. Lots and lots of shares."

IFUS certainly has the look of a penny stock OTC scam about it, and the fact that they file different figures for their share structure in different places is a real red flag.

I also note that it's promoted by some of the same folk that promote other confirmed penny stock scams, such as Spencer Pharmaceuticals.

Do you think that IFUS is on the up and up, or is it, like so many of these penny stock momo plays, a vehicle to enrich a small group of insiders, aided and abetted by the usual suspects?

"Hi Sunspotter, how to get the SEC to investigate SPPH?"

This is the correct form to send off to SEC:

https://denebleo.sec.gov/tcr/add.action?c=12

I suggest that you, and anybody else who feels that Pink Sheet scams such as Spencer Pharmaceuticals, by underming the probity of our financial markets, strike at the beating heart of Western Democracy, complete it.

I did several days ago, and I know of others who have also done so.

Perhaps if they get sufficient notices, SEC will act sooner rather than later.

Alternatively, it may be possible to get an Attorney General from one of the States interested - that can accelerate the process sometimes. As SPPH have an accomodation address in Boston, perhaps the Massachusetts AG would be a good place to start.

"a lot of peeps here are green, remember to take profits"

For all you traders with a position in Spencer Pharmaceuticals, that sounds like sound advice, particularly as the price per share of this palpable pump and dump could collapse any day - for example if the SEC come calling, or if the private Canadian hedge fund behind it decide it's time for the inevitable dump after the pump.

And as for anybody taken in by the endless banner advertising all over iHub (strange they can afford to do this, but not pay their erstwhile French research partner, INSA), or fooled by the paid coverage by the penny stock promoters or by paid posters on message boards (some disclosed, perhaps some not - see my next post) into taking a long term postion in SPPH as an investment, take this as notice that this is purely a short term play, and that nobody - nobody - thinks this is a serious company.

And if you want to see where this all ends, check out Dr. Max Arella's other scam company, Horizon International [sic], HZHI.

"everyday is one day closer to the 97 cents the company PR'd"

Now, then, "Pastor" Phil, you know the company surrounded that offer with more getaways than a medieval castle, and that it will never ever be consumated.

And the reason for all those caveats and safe harbor statements is because they hope that will protect them when it turns out that the "offer", just like the previous PRs about approvals by June 2011 in the US, Canada and the EU for Met4, is entirely fictional. (In fact a deliberate lie is a deliberate lie, and not covered by any safe harbor statement, of course.)

They've already admitted that the Met4 dates are utterly bogus (although they continue to commit scienters about the Canadian approval process).

If you want to see where SPPH is headed, look at HZHI, another scam chaired by Dr. Arella, but somewhat further along the downward spiral.

The reality is that:

everyday is one day closer to the day the company goes bankrupt or is suspended by SEC

and as the latter could come any time, any day now (or never at all), you'd wouldn't want to be caught holding a position when that happens.

And you would never ever want to be buying and holding this transparent scam.

"As for the suing those responsible, why waste more money?"

Because criminals should be held responsible for their crimes, and because setting a precedent of disgorgement of illegal gains discourages other fraudsters, that's why.

Those responsible for the losses some have taken here should be barred from future involvement with any security, stripped of their own assets, and if a Judge and Jury sees fit, sent to jail.

I can't imagine why anyone would argue otherwise.